News | April 04, 2011

Paul Scherrer Institute, Elekta Collaborate in Proton Therapy Development

April 4, 2011 – The Paul Scherrer Institute (PSI) in Switzerland and Elekta are collaborating to further develop treatment planning and oncology information systems (OIS) for proton therapy. Proton therapy is a form of external beam radiation that uses protons instead of X-rays or electrons to treat certain types of cancer and other diseases.

PSI integrated Elekta's XiO treatment planning system and MOSAIQ OIS into its Centre for Proton Therapy to manage the flow of information and image data between treatment delivery, treatment planning, treatment simulation and the patient's electronic medical record.

The company recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for XiO to plan spot scanning. Spot scanning a proton therapy delivery method that involves constructing a highly conformal placement of dose to the tumor by using thousands of small individual beamlets instead of a single large beam.

"Through XiO, Elekta provides a combination of advanced tools for scanned proton beam therapy. Elekta also provides a clear road map to further develop intensity modulated, image guided and adaptive proton therapy," said Antony Lomax, Ph.D., professor and head of medical physics at the Center for Proton Therapy at PSI. "A deciding factor in entering into this relationship was Elekta's willingness to leverage the significant experience of our team to increase the capabilities of XiO proton planning."

MOSAIQ is designed to support different types of radiation systems and modalities, including proton and carbon ion therapy, intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and volumetric modulated arc therapy (VMAT).

The Centre for Proton Therapy at PSI pioneered scanning beam proton therapy, and treated its first patients with this approach in 1996. Subsequently, PSI upgraded this treatment modality to deliver intensity modulated proton therapy (IMPT), treating its first patient with this technique in 1999.

"Radiation therapy is evolving rapidly in many areas, thanks in large part to innovations in intensity modulation, image guidance and workflow enhancing information management systems over the last decade," said Stewart Pegrum, director particle therapy, Elekta. "Elekta has driven most of these improvements on the linear accelerator, as centers such as the Paul Scherrer Institute have advanced the discipline of proton therapy. Our collaboration with PSI focuses on combining technological advances in conventional radiation therapy and proton therapy to create the best possible therapeutic solution. We firmly believe that both Elekta and its customers can substantially benefit from this collaboration as PSI is one of the leading institutions in the field of proton therapy."

For more information:

Related Content

DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
Eight Proton Therapy Centers Worldwide Adopt RayStation for Treatment Planning
News | Treatment Planning | July 21, 2017
RaySearch Laboratories reported that eight additional proton therapy centers worldwide have recently chosen RayStation...
IBA to Install Proton Therapy Facility at Inova Schar Cancer Institute
News | Proton Therapy | July 18, 2017
IBA (Ion Beam Applications S.A.) and Inova recently signed a contract for a two-room Proteus Plus proton therapy...
Proton International and Beaumont Health Open Michigan's First Proton Therapy Facility
News | Proton Therapy | July 17, 2017
Proton International (PI) and Beaumont Health recently opened the state’s first proton therapy center, offering the...
ASTRO Updates Insurance Coverage Recommendations for Proton Therapy
News | Proton Therapy | July 17, 2017
The American Society for Radiation Oncology (ASTRO) has issued an update to its recommendations for medical insurance...
IBA and Philips Step Up Commercial Collaboration in Brazilian Proton Therapy Market
News | Radiation Therapy | July 03, 2017
IBA and Philips announced in mid-June they are stepping up their combined effort for proton therapy in Brazil.
First Patient Treated With Pencil Beam Scanning at Institute Curie Proton Therapy Center
News | Proton Therapy | May 23, 2017
May 23, 2017 — IBA announced that the first patient has been treated with pencil beam scanning (PBS) technology at th
News | Radiation Therapy | May 16, 2017
Proton International announced the successful financing of a new state-of-the-art radiation therapy center and a...
Proton Monte Carlo Dose Calculation Now Part of RayStation Treatment Planning
News | Treatment Planning | May 15, 2017
RaySearch demonstrated a new Monte Carlo dose planning feature for proton therapy on its RayStation system at the 2017...
Work Starts on Belgium's First Proton Therapy Center
News | Proton Therapy | May 05, 2017
IBA announced that building works have begun on the Proton Therapy Center ParTICLe – Belgium’s first center for proton...
Overlay Init